- |||||||||| Trial completion, Enrollment change: GotNet Study, The Gothenburg Nurse-led Tight Control Study (clinicaltrials.gov) - May 19, 2017
P=N/A, N=70, Completed, N=252 --> 24 | Recruiting --> Suspended | Trial primary completion date: Apr 2017 --> Sep 2017 Active, not recruiting --> Completed | N=120 --> 70
- |||||||||| Trial completion: AbATE Follow-Up Study (clinicaltrials.gov) - May 18, 2017
P=N/A, N=44, Completed, N=16 --> 0 | Trial primary completion date: Dec 2015 --> Aug 2016 Active, not recruiting --> Completed
- |||||||||| aspirin / Generic mfg.
Trial completion, Trial primary completion date: Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis (clinicaltrials.gov) - May 18, 2017 P, N=12, Completed, Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Sep 2017 --> May 2017
- |||||||||| Enrollment open, Trial primary completion date: SPIRALE: Study During Pregnancy of Expression of miRNAs in RA or SLE (clinicaltrials.gov) - May 17, 2017
P=N/A, N=40, Recruiting, Recruiting --> Completed | Trial primary completion date: Sep 2017 --> May 2017 Not yet recruiting --> Recruiting | Trial primary completion date: Jan 2017 --> Jul 2019
- |||||||||| ozagrel ophthalmic (KCT-0809) / Teika, Ono Pharma, Kissei
Trial completion, Trial primary completion date: A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome (clinicaltrials.gov) - May 17, 2017 P3, N=0, Completed, Not yet recruiting --> Recruiting | Trial primary completion date: Jan 2017 --> Jul 2019 Recruiting --> Completed | Trial primary completion date: Jun 2017 --> Jan 2017
- |||||||||| Enrollment closed, Phase classification, Trial primary completion date: Clinical Trial of a Serious Game for Individuals With SCI/D (clinicaltrials.gov) - May 17, 2017
P=N/A, N=178, Active, not recruiting, Recruiting --> Completed | Trial primary completion date: Jun 2017 --> Jan 2017 Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A | Trial primary completion date: Sep 2018 --> Sep 2017
- |||||||||| Enrollment change, Trial termination: The Clinical Efficacy of DFPP in Patients With AAGN (clinicaltrials.gov) - May 16, 2017
P=N/A, N=14, Terminated, Trial primary completion date: Mar 2017 --> Oct 2018 N=70 --> 14 | Recruiting --> Terminated; The recruitment of subject is very difficult.
- |||||||||| Cimzia (certolizumab pegol) / Astellas, UCB
Enrollment closed, Phase classification, Trial primary completion date: NIMRA: Novel Imaging Markers for Rheumatoid Arthritis (clinicaltrials.gov) - May 15, 2017 P=N/A, N=40, Active, not recruiting, Recruiting --> Completed Enrolling by invitation --> Active, not recruiting | Phase classification: P4 --> PN/A | Trial primary completion date: May 2017 --> Jan 2018
- |||||||||| Orencia (abatacept) / BMS
Trial completion, P4 data, Combination therapy: Abatacept Post-marketing Clinical Study in Japan (clinicaltrials.gov) - May 15, 2017 P4, N=405, Completed, Enrolling by invitation --> Active, not recruiting | Phase classification: P4 --> PN/A | Trial primary completion date: May 2017 --> Jan 2018 Active, not recruiting --> Completed
|